Alicia Mundy, who has specialized in probing the links between FDA policy and lobbying efforts by drug-makers and other health care companies, delivered her first front page story on the subject in Friday's The Wall Street Journal.
Ms. Mundy, who joined the Journal in March 2008, penned the 2,500-word investigative story, Political Lobbying Drove FDA Process, in which she pours over internal FDA documents to report that "The recent approval of a new device to treat knee injuries followed a lobbying campaign that overcame repeated rejections" by FDA scientists.
The article focuses on Menaflex, made by New Jersey-based ReGen Biologics Inc., and quotes former FDA Commissioner Andrew von Eschenbach saying "we fumbled that process" when the agency agreed to fast-track approval of the product that is used to repair a torn meniscus in the knee. Mr. von Eschenbach was in charge of the government regulator at the time it allowed ReGen to skip past standard clinical trials on its path to approval. The FDA approved Menaflex on December 20th.
To support her reporting, Ms. Mundy cites "emails reviewed by the Journal," although she doesn't make clear how she obtained access to the internal FDA communications. This is similar to a story Ms. Mundy wrote on January 14th, Glaxo's Emails on Avandia Reveal Concern, in which she notes that Senator Chuck Grassley of Iowa was preparing a report "containing excerpts from Glaxo documents." In her Page One story, Ms. Mundy also mentions that Sen. Grassley "is also looking into the Menaflex approval process" -- making the Senator's office a leading candidate as the source of her materials.
Two other supportive sources Ms. Mundy cites are Jay Mabrey, the chief of orthopedic surgery at Baylor University Medical Center, who served as chairman of the FDA advisory committee weighing Menaflex; and Larry Kessler, who now heads the Health Services Department at the University of Washington, but who was previously with the FDA and directed the laboratory that reviewed Menaflex.
Dr. Kessler told Ms. Mundy the Menaflex approval "shows the FDA at its worst."
Ms. Mundy's past reporting has been controversial leading one critic affiliated with the Center for Medicine in the Public Interest to accuse her last year of her own conflicts-of-interest, having worked at as a New America Foundation Fellow prior to joining the Journal and written an article for the "far left" American Prospect magazine. Additional details are available in Ms. Mundy's Health.NewsBio.
Ms. Mundy is the author of Dispensing With The Truth, which alleges a deliberate deception by Wyeth-Ayerst (a division of American Home Products) pertaining to the risks of the diet drug, fen-phen.
Jared A. Favole, who covers the FDA for Dow Jones Newswires, is credited at the bottom of Ms. Mundy's front page story for having contributed reporting to it.
To order Ms. Mundy's full Health.NewsBios dossier, phone 866-NEWS-070, x.2. It is available, like that of dozens of other influential health journalists, for $69.95.
Cool,
Keep up the good work,
Thanks for bringing this up
Posted by: Software companies UK | 12/09/2009 at 08:59 AM
It is nice one, the pic is very cool, i just wonder if the real matter also cool enough. I have got a watch which have nice photo but do not really good before, it is so bad...
Posted by: Impotence causes | 10/05/2010 at 11:12 AM
Thierry Bodin, a member of the pharmaceutical company's union. Torsoli also quoted "two people familiar with the talks" in noting that Sanofi is seeking a new finance chief and has interviewed Jerome Contamine, the former finance head of Veolia Environment SA.
Posted by: Tiffany Jewelry | 10/27/2010 at 02:51 AM
Bad habits are the unlocked door to failure
Posted by: supra shoes | 11/07/2010 at 06:46 PM
Any which way you calculate it, I'm paying a lot less than I used to!
Posted by: uggs outlet | 11/10/2010 at 01:14 AM
the FT posts a video of Macintosh explaining why it makes more sense for giant pharma companies to own consumer products divisions than for giant consumer products companies to own pharma divisions.
Posted by: ugg classic tall | 11/10/2010 at 08:22 PM
It sounds so good, I want it!
Posted by: ugg store | 11/13/2010 at 01:59 AM
It is not enough to have a good mind; one must use it well.*
Posted by: coach outlet | 11/16/2010 at 02:07 AM
I appreciate the time you positioned on this concentrate on or on this post. even in spite of the reality that have fascinating ideas.
Posted by: ugg sale | 11/26/2010 at 01:05 AM
I would love to bookmark your blog as there are very interesting and encouraging articles!
Posted by: stock shoes | 11/30/2010 at 11:33 PM
A time for us someday there'll be a new world
a world of shining hope
For you and me.
Posted by: Air Jordans | 12/08/2010 at 01:41 AM
Beautiful post, great ))
Posted by: шторы в зал | 12/31/2010 at 05:09 PM
Less disappointing than life, great works of art do not begin by giving us all their best. Do you agree?
Posted by: Air Jordan | 03/07/2011 at 04:16 AM
Раскрутка групп vkontakte
Викинг ботовод — раскрутка В Контакте
Программа для раскрутки групп и профилей В контакте - Viking Botovod
На сегодняшний день практически у каждого пользователя интернета есть как минимум один аккаунт в какой-либо социальной сети. Конечно же все знают такого гиганта как Facebook. В российском сегменте лидером явно является социальная сеть «В контакте», о которой иногда я пишу заметки. Этот пост тоже будет о этой социальной сети, а точнее о раскрутке в ней. Сегодняшняя тема будет посвящена программе для раскрутки аккаунтов в этой социальной сети с помощью программы Викинг Ботовод. О том, что она умеет и как её получить читаем ниже.
Программа Викинг Ботовод, на мой взгляд, является очень хорошим инструментом для раскрутки аккаунтов и групп «В контакте».
Программа умеет следующее:
Добавлять друзей (по критериям, по спискам id, по возможным друзьям или же из групп)
Транслировать RSS поток на «стену» (скармливаем программе RSS и она будет писать на стену новые записи)
Управлять сразу несколькими аккаунтами (в программе есть встроенный браузер, с помощью которого не придется вводить по несколько раз пароли от страниц — можно просто переключаться между аккаунтами, использую мышь)
Поддержка сервиса antigate.com для распознавания капчи
Постинг информации на стены и в группы по расписанию (можно задать что писать и когда, а затем уже не задумываться что и где надо написать)
«Ботовод» будет полезен всем владельцам сайтов, с его помощью можно без особого труда увеличивать свою аудиторию. Трансляция RSS потоков будет очень по душе блоггерам, это ведь так удобно — не нужно руками нажимать на кнопки, всё сделает сама программа.
Получить программу:
Программу можно купить на официальном сайте, её стоимость на данный момент 1800р. Также на сайте есть и другие хорошие программы для раскрутки в социальных сетях, советую к ним тоже присмотреться.
Posted by: envemncentjap | 04/30/2011 at 01:12 PM
A very good and informative article indeed . It helps me a lot to enhance my knowledge, I really like the way the writer presented his views.
http://www.cheaphatcaps.com
Posted by: cheap Baseball Hats | 07/07/2011 at 03:48 AM
Alicia Mundy, who has specialized in probing the links between FDA policy and lobbying efforts by drug-makers and other health care companies, delivered her first front page story on the subject in Friday's The Wall Street Journal. Ms. Mundy, who joined the Journal in March 2008, penned the 2,500-word investigative story, Political Lobbying Drove FDA Process, in which she pours over internal FDA documents to report that The recent approval of a new device to treat knee injuries followed a lobbying campaign that overcame repeated rejections by FDA scientists. The article focuses on Menaflex, made by New Jersey-based ReGen Biologics...
Posted by: lexapro online | 07/12/2011 at 05:50 PM
That was a great piece of information, I enjoyed reading it. I am totally agree with your oppinion.this blog post is very encouraging to people who want to know these topics.I don't comment on many blogs but after reading a few of your posts I thought I would just say thanks and keep up the good work.
Posted by: tiffany Earrings | 07/12/2011 at 10:51 PM
Cool site http://buyonlinerx.com/ - buy proventil, buy propecia, buy cialis, online pharmacy and othe.
Posted by: DarmaWake | 09/24/2011 at 01:55 AM
cash on delivery Phenergan no rx changes
discount online xanax pause
buy soma next day discover
chlamydia dosage zithromax Receivd
buy soma no rx needed pages
cod pharmacy Cytotec barendssatx
lisinopril
soma order online Diana
online Acyclovir cod vidalrandolph
ambien online order cheapest dg
post office usps tramadol cheap ultram MapBerikut
tramadol nerve pain Diamond
tramadol saturday delivery cod visibilityclothes
buy overnight tramadol coals6
Trazodone online injuries
cod overnight Prednisone graceful
cheap order prescription Nolvadex unresponsive
cash for tramadol ditentukan
Buspar and online overnight delivery enoughthough
cheap ultram overnight Infoseek
generic cialis from india ModuleAdmin
ultram overnight cod sgmnbruceaol
viagra 50 mg Allridge
buy online Buspar bugle
Posted by: rigrqvukaK | 09/27/2011 at 02:06 AM
I follow you VIA GFC and I love your blog!
Posted by: Belstaff chaquetas | 11/07/2011 at 03:21 PM
That was a really good writing!
Posted by: timberline shingles barkwood | 11/21/2011 at 12:06 PM
No offense, but if there's a facebook like button, it'll be much easier for me to share.
Posted by: elliptical reviews | 11/29/2011 at 11:25 PM
YYKAYRFVBB canada goose trillium parka GGKKLNKCUA http://cheapuggbootsonline589.quicksnake.com/shopping/canada-goose-parka-have-a-good
Posted by: BralCankilk | 12/26/2011 at 01:59 AM
wVkfPjzXa cheap uggs tKnpMzhWt http://dingdingmao.besthometreadmill.co.za/2011/12/26/cheap-uggs-shorter-sexual/ hWwgPbcNu uggs zGdhEjnTe http://www.short-articles.net/ugg-boots-clearance-is-method-of-the-ugg/
Posted by: plaigiota | 12/27/2011 at 01:10 AM
dElqFkdVn ugg boots cheap sale aHpbLtfZe http://www.netblogg.se/uggbootssale20/36067/cheap+ugg+boots+for+women.html
Posted by: Erelehagbah | 12/27/2011 at 01:56 AM